A.I.dvisor tells us that ACHV and GLYC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACHV and GLYC's prices will move in lockstep.
Ticker / NAME | Correlation To ACHV | 1D Price Change % | ||
---|---|---|---|---|
ACHV | 100% | +2.98% | ||
GLYC - ACHV | 33% Poorly correlated | -8.51% | ||
CDTX - ACHV | 30% Poorly correlated | -4.89% | ||
SNPX - ACHV | 28% Poorly correlated | -1.45% | ||
AVRO - ACHV | 27% Poorly correlated | +0.66% | ||
ARRY - ACHV | 27% Poorly correlated | -1.99% | ||
More |
Ticker / NAME | Correlation To ACHV | 1D Price Change % |
---|---|---|
ACHV | 100% | +2.98% |
pharmaceuticals (undefined stocks) | 27% Poorly correlated | -0.92% |
north america (undefined stocks) | 26% Poorly correlated | +0.06% |
biotechnology (undefined stocks) | 25% Poorly correlated | -1.59% |
drugs (undefined stocks) | 20% Poorly correlated | -1.35% |